Why it was recalled
Product found to be Sub Potent or Exceeded reconstitution time
Product description
NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate Monobasic USP, 0.42% Sodium Phosphate Dibasic USP, 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835 NDC: 73198-0083-00
Lot numbers, UPCs & expiration codes
Lot: D24005 Exp. 4/5/22; C41008 Exp. 3/8/22
Where it was sold
Nationwide in the USA including Puerto Rico.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0719-2022
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Mar 8, 2022
- FDA report date
- Mar 30, 2022
- Quantity
- 2634 vials
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Olympia Compounding Pharmacy dba Olympia Pharmacy
Original FDA data
Every field from FDA enforcement report D-0719-2022, exactly as published.
Show all FDA fields
- City
- Orlando
- State
- FL
- Status
- Terminated
- Country
- United States
- Event ID
- 89717
- Address
- 6700 Conroy Rd Ste 155
- Code information
- Lot: D24005 Exp. 4/5/22; C41008 Exp. 3/8/22
- Postal code
- 32835-3515
- Report date
- Mar 30, 2022
- Product type
- Drugs
- Recall number
- D-0719-2022
- Classification
- Class II
- Recalling firm
- Olympia Compounding Pharmacy dba Olympia Pharmacy
- Product quantity
- 2634 vials
- Termination date
- Oct 4, 2023
- Reason for recall
- Product found to be Sub Potent or Exceeded reconstitution time
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate Monobasic USP, 0.42% Sodium Phosphate Dibasic USP, 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835 NDC: 73198-0083-00
- Distribution pattern
- Nationwide in the USA including Puerto Rico.
- Recall initiation date
- Mar 8, 2022
- Initial firm notification
- Letter
- Center classification date
- Mar 29, 2022